Earlier, another trial in China testing the drug in those with severe COVID-19 was terminated because no eligible patients could be enrolled. China, where the outbreak is believed to have originated, has been able to control it through tough measures such as lockdowns. The study was conducted by researchers in China and the suspension was posted https://bit.ly/3bcnyv4 on Wednesday on clinicaltrials.gov, a database maintained by the U.S. National Institutes of Health (NIH).
from Yahoo News - Latest News & Headlines https://ift.tt/3emNbew
via IFTTT
Comments
Post a Comment